Metosuccinat Sandoz

Metoprolol Tartrate, the active ingredient in Metosuccinat Sandoz, is a beta blocker presented as a tablet for oral use. It is used to manage high blood pressure, angina pectoris, heart failure, and certain cardiac arrhythmias in adult patients, and to improve survival after myocardial infarction.

GNH USA supplies Metosuccinat Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. Our distribution network ensures timely delivery to diverse healthcare settings across continents.

Metoprolol Tartrate, a selective β1‑adrenergic blocker, is employed in several cardiovascular conditions.

- Hypertension: lowers blood pressure and reduces long‑term cardiovascular risk. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Myocardial infarction: improves survival when started early after an acute event. - Heart failure: reduces mortality and hospitalisation by decreasing cardiac workload. - Cardiac arrhythmias: controls heart rate in atrial fibrillation and other supraventricular tachyarrhythmias.

Metoprolol Tartrate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Fatigue or general weakness. - Dizziness or light‑headedness, especially on standing. - Cold extremities such as hands and feet. - Gastrointestinal upset, including nausea or abdominal discomfort.

Serious or Rare Side Effects: - Severe bradycardia or heart block. - Marked hypotension leading to fainting. - Bronchospasm, particularly in patients with reactive airway disease. - Allergic reactions such as rash, angioedema, or anaphylaxis. - Depression or mood changes. - Worsening heart failure in susceptible individuals.

When prescribing Metosuccinat Sandoz, clinicians should consider several safety measures. - Dose adjustment: reduce dose in patients with renal or hepatic impairment. - Cardiovascular monitoring: observe heart rate and blood pressure after initiation or dose changes. - Caution in asthma or COPD: monitor for bronchospasm due to β‑blockade. - Interaction awareness: review concomitant medications that affect cardiac conduction. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Metosuccinat Sandoz can interact with a variety of medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective beta blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): risk of severe AV block. - Clonidine: abrupt discontinuation may cause rebound hypertension.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes and blood pressure for additive effects. - ACE inhibitors or ARBs: watch for excessive hypotension. - Antidiabetic agents: beta‑blockade may mask hypoglycaemia symptoms. - Antidepressants (especially SSRIs): may increase plasma metoprolol levels.